Advances in targeting drug delivery to glomerular mesangial cells by long circulating cationic liposomes for the treatment of glomerulonephritis

Pharmaceutical Research

Volumn 24, Issue 5, 2007, Pages 946-954

  Morimoto, Katsumi ^a   Kondo, Masayo ^a   Kawahara, Kazuo ^a   Ushijima, Hideto ^a   Tomino, Yasuhiko ^b   Miyajima, Masaharu ^a   Kimura, Junji ^a  

^a TERUMO CORPORATION   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Active targeting; Cationic liposomes; Glomerulonephritis; Polyethylene glycol; Prednisolone phosphate

Indexed keywords

3,5 DIPENTADECYLOXYBENZAMIDINE; LIPOSOME; MACROGOL; PREDNISOLONE 21 PHOSPHATE; SMOOTH MUSCLE ACTIN; SODIUM CHLORIDE; TRX 20; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG FORMULATION; DRUG TARGETING; GLOMERULONEPHRITIS; GLOMERULUS; INTERNALIZATION; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TARGET CELL;

ANIMALS; BENZAMIDINES; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; FATTY ACIDS; GLOMERULONEPHRITIS; INJECTIONS, INTRAVENOUS; LIPOSOMES; MALE; MESANGIAL CELLS; MICROSCOPY, FLUORESCENCE; MOLECULAR STRUCTURE; PREDNISOLONE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 34247647106     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9213-0     Document Type: Article

References (22)

1. V. P. Torchilin. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4:145-160 (2005).
2. A. L. Klibanov, K. Maruyama, V. P. Torchilin, and L. Huang. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:235-237 (1990).
3. T. M. Allen, C. Hansen, F. Martin, C. Redemann, and A. Yau-Young. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066:29-36 (1991).
4. D. D. Lasicand and D. Papahadjopoulos. Liposomes revisited. Science 267:1275-1276 (1995).
5. T. Harigai, M. Kondo, M. Isozaki, H. Kasukawa, H. Hagiwara, H. Uchiyama, and J. Kimura. Preferential binding of polyethylene glycol-coated liposomes containing a novel cationic lipid, TRX-20, to human subendthelial cells via chondroitin sulfate. Pharm. Res. 18:1284-1290 (2001).
6. K. Kawahara, A. Sekiguchi, E. Kiyoki, T. Ueda, K. Shimamura, Y. Kurosaki, S. Miyaoka, H. Okabe, M. Miyajima, and J. Kimura. Effect of TRX-liposomes size on their prolonged circulation in rats. Chem. Pharm. Bull. (Tokyo) 51:336-338 (2003).
7. S. Klahr, G. Schreiner, and I. Ichikawa. The progression of renal disease. N. Engl. J. Med. 318:1657-1666 (1988).
8. R. J. Johnson. The glomerular response to injury: progression or resolution? Kidney Int. 45:1769-1782 (1994).
9. J. V. Donadio Jr. and J. P. Grande. Immunoglobulin A nephropathy: a clinical perspective. J. Am. Soc. Nephrol. 8:1324-1332 (1997).
10. J. Liao, K. Hayashi, S. Horikoshi, H. Ushijima, J. Kimura, and Y. Tomino. Effect of steroid-liposome on immunohistopathology of IgA nephropathy in ddY mice. Nephron 89:194-200 (2001).
11. J. A. Jefferson and R. J. Johnson. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J. Nephrol. 12:297-307 (1999).
12. C. M. Lee, T. Tanaka, T. Murai, M. Kondo, J. Kimura, W. Su, T. Kitagawa, T. Ito, H. Matsuda, and M. Miyasaka. Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo. Cancer Res. 62:4282-4288 (2002).
13. D. L. Daleke, K. Hong, and D. Papahadjopoulos. Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. Biochim. Biophys. Acta 1024:352-366 (1990).
14. F. Van Bambeke, A. Kerkhofs, A. Schanck, C. Remacle, E. Sonveaux, P. M. Tulkens, and M. P. Mingeot-Leclercq. Biophysical studies and intracellular destabilization of pH-sensitive liposomes. Lipids35:213-223 (2000).
15. H. Morita, K. Maeda, M. Obayashi, T. Shinzato, A. Nakayama, Y. Fujita, I. Takai, H. Kobayakawa, I. Inoue, and S. Sugiyama Induction of irreversible glomerulosclerosis in the rat by repeated injections of a monoclonal anti-Thy-1.1 antibody. Nephron 60:92-99 (1992).
16. H. Maeda, T. Sawa, and T. Konno. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control. Release 74:47-61 (2001).
17. M. B. Bally, H. Lim, P. R. Cullis, and L. D. Mayer. Controlling the drug delivery attributes of lipid-based drug formulations. J. Liposome Res. 8:299-335 (1998).
18. G. J. Thomas, R. M. Mason, and M. Davies. Characterization of proteoglycans synthesized by human adult glomerular mesangial cells in culture. Biochem. J. 277(Pt 1), 81-88 (1991).
19. G. J. Thomas, L. Shewring, K. J. McCarthy, J. R. Couchman, R. M. Mason, and M. Davies. Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium. Kidney Int. 48:1278-1289 (1995).
20. L. Schaefer, H. Hausser, M. Altenburger, J. Ugorcakova, C. August, L. W. Fisher, R. M. Schaefer, and H. Kresse. Decorin, biglycan and their endocytosis receptor in rat renal cortex. Kidney Int. 54:1529-1541 (1998).
21. R. J. Johnson, H. Iida, C. E. Alpers, M. W. Majesky, S. M. Schwartz, P. Pritzi, K. Gordon, and A. M. Gown. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J. Clin. Invest. 87:847-858 (1991).
22. C. E. Alpers, K. L. Hudkins, A. M. Gown, and R. J. Johnson. Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int. 41:1134-1142 (1992).